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The Hedamycin Locus Implicates a Novel Aromatic
PKS Priming Mechanism
are primed by different starters [1]. Even though the
mechanism of attachment of alternative primers on type
II PKSs is not thoroughly understood, recent findings
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1Laboratory for Biosynthetic Chemistry support two alternative pathways for unique starter unit
discretion by aromatic PKS systems. In the case ofPharmaceutical Sciences Division
School of Pharmacy benzoate-, salicylate-, or malonamate-derived polyke-
tides, the corresponding biosynthetic gene cluster con-University of Wisconsin-Madison
777 Highland Avenue tains a monofunctional CoA ligase and an acyltransfer-
ase (AT) that are putatively responsible for activationMadison, Wisconsin 53705
2 Molecular Pharmacology and Therapeutics and transfer of the parent starter units onto the PKS [1].
In the case of daunorubicin (1, dps), aclacinomycin (2,Program
The Sloan-Kettering Division akn), frenolicin (3, fren), and R1128 (4–7, zhu) biosynthe-
sis (Figure 1A), where the PKS is primed by short-chainJoan and Sanford I. Weill Graduate School
of Medical Sciences fatty acids, a second catalytic ketosynthase module
(KSIII), an AT, and, in the latter two, an additional ACPCornell University
1275 York Avenue are postulated to be involved [1–6].
Hedamycin (Figure 1B, 14) is an aromatic polyketideNew York, New York 10021
produced by Streptomyces griseoruber [7] and has
gained considerable recognition as a highly selective
DNA alkylating agent. Unlike simple DNA alkylatingSummary
agents that react preferentially at guanines found in
polyguanine sequences, 14 acts both via reversible DNAThe biosynthetic gene cluster for the pluramycin-type
intercalation and irreversible alkylation of a guanineantitumor antibiotic hedamycin has been cloned from
residue at specific 5-PyG-3 motifs, with 5-CGT sitesStreptomyces griseoruber. Sequence analysis of the
favored over 5-TGT sites [8–12]. While this natural45.6 kb region revealed a variety of unique features
product demonstrates a significant range of biologicalsuch as a fabH homolog (KSIII), an acyltransferase
responses [13, 14], it is not currently used clinically(AT) gene, a set of type I polyketide synthase (PKS)
because of a low therapeutic index. Hedamycin is agenes, and two putative C-glycosyltransferase genes.
member of the classical pluramycin antitumor antibio-As the first report of the cloning of the biosynthetic
tics (Figure 1B) and consists of a planar 4-H-anthragene cluster for the pluramycin antibiotics, this work
(1,2-b )pyran chromophore, which carries two proximalsuggests that the biosynthesis of pluramycins utilize
amino sugars critical for activity, -L-N,N-dimethylvan-an iterative type I PKS system for the generation of a
cosamine (3-dimethylamino-2,3,6-trideoxy-3-C-methyl-novel starter unit that subsequently primes the type II
-L-lyxo-hexopyranose) and -D-angolosamine (3-dimeth-PKS system. It also implicates the involvement of a
ylamino-2,3,6-trideoxy--D-arabino-hexopyranose),second catalytic ketosynthase (KSIII) to regulate this
and a distal bisepoxide-containing side chain requiredunusual priming step. Gene disruption is used to con-
for DNA alkylation [9, 12, 15]. The biosynthetic originfirm the importance of both type I and II PKS genes
of this unique side chain is unknown, but its unusualfor the biosynthesis of hedamycin.
structure suggests the possibility of an alternative prim-
ing of an aromatic PKS.
Introduction Hedamycin is also clearly distinguished by its unique
di-C-glycosidic architecture. The chemistry of C-glyco-
Aromatic polyketides are widely distributed in bacteria, sides, defined as compounds in which an exo-cyclic
fungi, and plants, and many are clinically valuable agents oxygen atom of an O-glycoside is replaced by a carbon
(e.g., tetracyclines and daunorubicin) or exhibit other atom, has been of considerable interest over the last 20
fascinating biological activities. In bacteria these com- years (Figure 1C) [16]. Unlike their O-glycoside counter-
pounds are usually biosynthesized by type II polyketide parts, C-glycosides are unaffected by hydrolytic or
synthases (PKSs), which minimally consist of the KS/ enzymatic cleavage and possess a level of chemical
KS heterodimer, also referred to as the ketosynthase- stability comparable to that of cyclic ethers. Thus,
chain length factor (KS-CLF); an acyl carrier protein C-glycosides are ideally suited for use as stable sugar
(ACP); and a malonyl-CoA:ACP transacylase (MCAT). mimics. Based upon synthetic chemistry precedent,
This minimal PKS initiates polyketide biosynthesis by some naturally occurring aryl C-glycosides are pre-
decarboxylation of malonyl-ACP, which is catalyzed by sumed to arise via an ortho-O-C rearrangement, giving
the KS/KS complex and leads to incorporation of an rise to a preferred -substitution [17, 18]. However, this
acetate starter unit. Despite the widespread occurrence biosynthetic postulation has not been tested. Further-
of acetate-primed polyketides, some bacterial aromatic more, while a similar mechanism might be invoked to
PKSs deviate from the decarboxylation mechanism and explain the novel ortho-, para-di-C-glycosyl substitution
in 14, chemical precedent has not been demonstrated.
Thus, the 14 system not only presents the potential to*Correspondence: jsthorson@pharmacy.wisc.edu
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Figure 1. Representative Naturally Occurring Aromatic Polyketides
(A) Metabolites that are primed by nonacetate starter units: Daunorubicin. (1), Aclacinomycin (2), Frenolicin (3), and R1128 (4–7).
(B) Pluramycin antitumor antibiotics.
(C) Aryl-C-glycosides: Urdamycin (16), Medermycin (17), Gilvocarcin (18), and Simocyclinone (19).
explore unique type II PKS priming but also offers a synthesis. This work represents the first elucidation of
a locus encoding for the biosynthesis of a pluramycinsuperb opportunity to delve into the unknown mecha-
nisms of both ortho- and para-C-glycosyltransfer. class antitumor antibiotic and should have direct rele-
vance toward understanding the biosynthesis of otherHerein we report the cloning and characterization of
the core of the biosynthetic gene cluster encoding for members within this important class of natural product.
Moreover, the utilization of a novel mechanism of a type14 biosynthesis (Figure 2), which reveals a starter unit-
specific KSIII and an AT reminiscent of the dps, akn, I and II PKS participation for the generation and transfer
of a starter unit for aromatic polyketide biosynthesis iszhu, and fren pathway. However, distinct from these
previously elucidated loci, a unique feature of this clus- the first of its kind. These studies also provide the first
available insights into di-C-glycosylation and cumula-ter is the utilization of an iterative type I PKS system,
HedT and HedU, which we propose to be critical for the tively present a variety of potential new tools for combi-
natorial pathway engineering toward novel aromaticgeneration of a hexenoate starter unit to serve as a
special primer for subsequent aromatic polyketide bio- polyketides.
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Figure 2. Organization of the 14 Biosynthetic Gene Cluster
The 32 ORFs indicated above derive from two overlapping cosmids JST101-201, the boundaries of which are highlighted. The genes unique
to this cluster—namely the ones encoding the AT, two C-glycosyltransferases, KSIII, and the two modular PKS proteins—are highlighted by
colored circles. Postulated functions associated with each of the genes and closest homologs are outlined in Table 1.
Results and Discussion Confirmation of the Hedamycin Locus
by PKS Disruption
Cloning and Sequencing of the Hedamycin As previously mentioned the KS gene (hedC in the 14
Biosynthetic Genes locus) codes for an essential component of the KS/KS
In an effort to clone the 14 biosynthetic genes, a heterodimer, which catalyzes the Claisen-like condensa-
S. griseoruber genomic library in E. coli was generated. tion reaction iteratively in aromatic polyketide biosyn-
Degenerate primers were designed to amplify the highly thesis. To confirm that the identified locus is responsible
conserved aromatic PKS gene, KS, and similarly con- for 14 biosynthesis, a KS disruption was performed. Spe-
served sugar biosynthetic genes such as the NDP-hex- cifically, protoplast transformation of wild-type S. griseo-
ose-4-6-dehydratase and glycosyltransferase genes [19– ruber by an E. coli vector carrying the hedC internal
21]. The degenerate primer sets were directly used to fragment and the apramycin resistance gene (aac(3)IV)
screen the genomic library by PCR. Five hundred single produced a resistant transformant named TBMC. Suc-
colonies from the genomic library were picked and cessful integration of the delivery vector via homologous
screened by pooling the colonies into groups of 50 for recombination into the targeted gene on the chromo-
PCR. To deconvolute positive pools, the screen was some was confirmed by Southern hybridization (Figures
repeated iteratively on a decreasing number of mixed 3A and 3B). As expected disruption of this essential
colonies until a single clone was identified. A positive biosynthetic gene resulted in the complete loss of 14
result was determined by amplification of the predicted production in this mutant strain, indicating that the cor-
size DNA fragment and confirmation by sequencing. rect locus has been cloned (Figure 4).
Cosmid JST101 amplified all three target genes in the To determine the significance of the type I PKS genes
screen and was subsequently submitted to shotgun se- in hedamycin production, a hedT disruption mutant was
quencing. Specific primers designed from the ends of generated by using conjugational transfer of plasmids
cosmid JST101 were then used to rescreen the library from E. coli. An apramycin resistant exconjugant named
and, in doing so, an overlapping cosmid, JST201, was TBMT was analyzed as above (Figures 3C and 3D). As
identified and also shotgun sequenced. Analysis of the illustrated in Figure 4, disruption of hedT also completely
final contiguous 45.6 kb DNA segment revealed the abolished antibiotic production, which highlights the
presence of 32 open reading frames (ORFs) that encode essential nature of the type I PKS genes for 14 biosyn-
proteins most homologous to enzymes involved in sec- thesis.
ondary metabolite production. Figure 2 shows a map of
the completely sequenced cluster. The proposed func-
Aglycon Assemblytion for the 32 ORFs and closest homologs are listed
In most cases the minimal PKS, consisting of a KS/KSin Table 1. Similarly, a 25 kb DNA fragment from the
heterodimer and the ACP, is primed via decarboxylationpluramycin A (12) producer S. pluricolorescens was
of a malonyl unit to yield an acetyl-S-KS intermediatecloned and sequenced, and sequence analysis revealed
that is subsequently elongated. However, some bacte-most of the genes found in the 14 locus (T.B., C.-G.H.,
and J.S.T., unpublished data). rial aromatic PKSs are primed by alternative primer
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Table 1. Deduced Function of the Hedamycin ORFs Shown in Figure 2
Closest Protein Homolog, Strain, Accession
Gene Amino Acid Proposed Function Identity, Similarity (%) Number
orfH1 505 Membrane transport protein Mct, S. lavendulae, 23, 33 AAD29366
orfH2 222 TetR-family regulatory protein S. avermitilis MA-4680, 24, 36 BAC68287
hedA 259 Keto reductase AknA, S. galilaeus, 67, 76 BAB72043
hedB 321 Cyclase Med-ORF3, S. sp. AM7161, 43, 53 AB103463
hedC 422 KS SimA1, S. antibioticus, 68, 77 AF3244838
hedD 421 KS TcsE, S. aureofaciens, 46, 56 BAB12567
hedE 319 Cyclase/dehyd. KinD, S. murayamaensis, 47, 60 AAO65350
and ACP fusion NcnC, S. arenae, 43, 62 AAD20269
hedF 325 Acyltransferase AknF, S. galilaeus, 51, 60 BAB72049
orfH3 541 Transaminopeptidase S. lividens, 27, 36 AAA92338
hedG 411 Monooxygenase Mesorhizobium loti, 35, 48 NP_105618
hedH 242 N,N-di-Methyltransferase DesVI, S. venezuelae, 53, 69 AAC68678
hedI 325 4,6-Hexoseketoreductase SnogG, S. nogalater, 45, 55 CAA12010
hedJ 379 Glycosyltransferase CmmGII, S. griseus, 39, 46 CAE17548
hedK 226 3,5-Epimerase StaE, S. sp. TP-A0274, 57, 68 BAC55217
orfH4 364 Hypothetical protein S. avermitilis MA-4680, 41, 54 CAB36600
orfH5 272 Regulatory protein Dnr I, S. peucetius, 53, 69 P25047
orfH6 334 ATP-binding protein AviABC1, S. viridochromogenes, 51, 68 AAG32068
orfH7 260 ABC transporter AviABC2, S. viridochromogenes, 35, 57 BAB69284
hedL 380 Glycosyltransferase Gra-orf14, S. violaceoruber, 44, 59 CAA09635
hedM 372 Aminotransferase Med-ORF20, S. sp. AM7161, 77, 82 BAC79028
hedN 321 Diphospho-4-keto-2,3,6- Med-ORF14, S. sp. AM7161, 48, 57 BAC79033
trideoxyhexulose reductase
hedO 239 N,N-di-Methyltransferase SnogX, S. nogalater, 57, 68 T46679
orfH8 228 ACP-phosphodiesterase S. coelicolor, 39, 51 Q9S1U6
orf H9 348 Transcription repressor DnrO, S. peucetius, 40, 60 AAD15248
orfH10 273 Putative hydroxylase SnoaW, S. nogalater, 42, 57 AAF01810
hedP 480 2,3-Hexose dehydratase SnogH, S. nogalater, 62, 73 CAA12009
hedQ 115 Anthrone oxygenase AknX, S. galilaeus, 48, 58 BAB72044
orfH11 760 UvrA-like drug resistance protein DrrC, S. peucetius, 49, 66 AAB39274
hedR 409 Cytochrome P450 S. carbophilus, 39, 54 JC4287
hedS 348 Putative 3-oxoacyl-ACP synthase DpsC, S. peucetius, 48, 61 AAA65208
hedT 985 Type I PKS; KSq (20-428), ATL OleAI, S. antibioticus, 44, 54 AAF82408
(542-859), ACPL (923-969)
hedU 2125 Type I PKS; KS (48-471), AT BorA3, S. parvulus, 41, 53 CAE45669
(574-888), DH (918-1035), KR
(1378-1557), ACP (1652-1712),
KS (1766-2124)
Figure 3. Generation of the PKS Mutants TBMC & TBMT
(A and C) Diagram showing insertion of the delivery vector containing aac(3)IV into the target genes hedC and hedT in the cluster via
homologous recombination.
(B) Two replica blots containing DNA from the wild-type and the hedC mutant TBMC digested with SmaI were probed with a 1.1 kb hedC
fragment and an aac(3)IV probe.
(D) Two replica blots containing DNA from the wild-type and the hedT mutant TBMT digested with NcoI were probed with a 2.75 kb hedT
fragment and an aac(3)IV probe.
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II disruption experiments clearly support the critical na-
ture of both sets of PKSs to 12 and 14 production.
Based upon this information, we propose that a unique
hexenoate starter unit is constructed by the type I PKS
and is subsequently utilized to prime the type II PKS
(Figure 5). One of the type I PKS proteins in this system,
HedT, contains a KS, an AT, and an ACP domain. Consis-
tent with other systems, the active site cysteine in the
HedT KS domain is replaced by a glutamine, suggesting
that it serves as the loading module [1]. In such systems
the KS domain has been shown to be able to decarboxyl-
ate malonyl-CoA to produce an acetyl starter unit [26].
HedU carries KS, AT, ACP, ketoreductase (KR), and
dehydratase (DH) domains and a second KS domain.
Examination of the AT domains in these modular pro-
teins show that both contain the conserved motifs re-
quired for malonyl-CoA transfer. Therefore we hypothe-
size that the second module is used iteratively to
elongate the acetyl starter unit with two malonyl-CoA
and subsequent 2-fold keto-reduction and dehydration
gives 20 (Figure 5).
Although rare, iterative type I PKS systems have been
reported to participate in forming the substituted orsel-
linc acid moieties of avilamycin and calicheamicin, and
the naphthalinic acid moiety of neocarzinostatin [27–29].
There are also recent reports in which iteration, or the
use of one module twice, occurs as a programmed eventFigure 4. Phenotypic Characterization of the PKS Mutants TBMC
in the biosynthesis of modular PKS products such asand TBMT
stigmatellin, aureothin, and borrelidin [30–34]. In a simi-HPLC profiles are presented on the left and B. subtilis bioactivity
assays are illustrated on the right where zones of inhibition (e.g. [A] lar manner, we postulate the 14 pathway utilizes a dedi-
and [B]) represent positive activity. (A) A 14 standard. (B) An extract cated type I PKS iteratively to biosynthesize a specific
from a 100 ml culture of the 14-producing S. griseoruber. (C) Extract hexenonate starter unit to prime aromatic polyketide
from a 100 ml culture of TBMC. (D) Extract from a 100 ml culture of biosynthesis. This remarkable participation of a type I
TBMT.
and II system is not commonly seen in bacteria. How-
ever, the fungal aflatoxin-producers A. nidulans and
units. The presence of a second catalytic KSIII module, A. parasiticus utilize a pair of specialized fatty acid syn-
an AT, and in some cases an additional ACP, is believed thases (Fas-1 A/Fas-2 A) to construct and present a
to be indicative of nonacetate-primed aromatic PKSs hexanoate starter unit to a simple type I PKS (PksA),
[1]. In accordance with this model the 14 cluster contains which then completes the synthesis of norsolorinic acid
hedS and hedF, which encode a KSIII and an AT, respec- en route to aflatoxin [35, 36].
tively. The closest homlogs of these genes, dpsC and As in the case with daunorubicin biosynthesis, we
dpsD, respectively, are found in the dps gene cluster, postulate that the KSIII encoded by hedS is likely to
and recent studies have localized the observed specific- play a role in the specificity of the type II PKS to utilize
ity of the daunorubicin PKS toward a propionyl starter the hexenoate starter unit over the normal malonyl-
unit to the DpsC protein (S. peucetius, S. sp. Strain C5) decarboxylation mechanism [22, 23]. Knockout studies
[22, 23]. R1128 is the other well-studied aromatic PKS have shown that in the absence of dpsC, the daunorubi-
system that contains homologs to dpsC and dpsD and cin type II PKS complex behaves promiscuously, utiliz-
an additional ACP gene. In vitro characterization of the ing both acetyl-CoA and propionyl-CoA as starter units.
unique R1128 system has shown that the minimal PKS Comparison of HedS to the known KSIIIs from aromatic
system and the KSIII in this cluster recognize orthogonal polyketide biosynthetic gene clusters (dps, akn, fren, zhu)
sets of ACPs, and the additional ACP is indispensable reveals that it is more homologous to DpsC and AknE2
for the incorporation of nonacetate primer units [24]. (61% and 54%, respectively) than to ZhuH and FrenI
More recently, Khosla et al. have successfully demon- (20% and 43%, respectively). HedS, DpsC, and AknE2
strated the ability to introduce novel primer units to also all lack the highly conserved active site cysteine,
aromatic polyketides by using the R1128 initiation mod- which is replaced by a serine, while ZhuH and FrenI
ule [25]. maintain the conserved residue. The absence of an addi-
The unprecedented physical link between a typical tional ACP in the three biosynthetic gene clusters is
set of aromatic PKS genes and genes encoding two another common denominator, suggesting that these
type I multimodular PKSs, a KSIII and an AT, as seen proteins perhaps function similarly to give the observed
in both the 12 and 14 loci, suggests that the biosynthesis specificity of the type II PKS system for its respective
of pluramycins require a unique dependence of addi- nonacetate starter unit.
tional proteins beyond the normal aromatic polyketide Once presented with the appropriate starter unit, the
type II PKS in the 14 locus is proposed to catalyze theassembly machinery. Furthermore, the type I and type
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Figure 5. The Proposed Biosynthetic Pathway for 14 and Related Pluramycins
The collaborative action of the starter unit-specific HedS (KSIII) and HedF (AT), in conjunction with an adjacent iterative type I PKS system
(HedT and HedU) for the generation and utilization of a de novo hexenoate primer for subsequent aromatic polyketide biosynthesis, is
specifically noted.
elongation of intermediate 20 to make the -polyketo- orhodin A biosynthesis (S. sp. JP95) [37, 38]. We propose
that these proteins likely play a role in epoxide formation,acyl chain precursor 21 (Figure 5). The early biosynthetic
enzymes closely related with the minimal PKS include which constitutes the alkylating ability of the compound.
HedQ encodes a protein with high similarity to oxy-a ketoreductase and aromatase/cyclase involved in
modification of the nascent polyketide chain [19]. Homo- genases that have been proposed to be involved in
quinone formation in the anthracycline polyketides suchlogs of these enzymes are found in this cluster and are
presumed to be important for the regioselective aromati- as aclacinomycins and nogalamycin. Despite the fact
that we have not yet identified a methyltransferase genezation of the open-chain precursor to form intermediate
22. The final steps of aglycon biosynthesis are presumed in the current locus, we presume that one is involved in
introducing the distal bis-epoxide methyl group.to be catalyzed by the cluster encoded putative PKS
oxygenases. The hedG gene encodes a protein with a
low homology to FAD-dependent monooxygenase, and Aglycon Modification
One of the novel features of 14 is the C-glycosidic at-HedR is most similar to oxygenases of the cytochrome
P450 family and bears 40% similarity to Grh03, which tachment of two distinct sugars to the aglycon, a pro-
cess anticipated to require two glycosyltransferasesis presumed to catalyze the epoxide formation in grise-
A Novel Aromatic PKS Priming Mechanism
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Figure 6. Two Proposed Mechanisms for C-Glycosylation
(A) Mechanism I illustrates an O-C rearrangement as proposed for the C-glycosylation of ortho-C-substituted C-glycosides.
(B) Mechanism II depicts direct aromatic substitution possibly promoted by the ortho/para-directing aromatic hydroxyl group.
with unique regio- and stereoselectivity. HedJ and HedL, transferase involved in the biosynthesis of vancomycin-
group antibiotics, GtfB, has revealed several additionalhomologous to various glycosyltransferases involved in
secondary metabolite production, are the candidate conserved motifs and residues [43]. Particularly note-
worthy are the highly conserved Gly-rich sequenceC-glycosyltransferases (Figure 5). HedJ greatly resem-
bles Med-Orf8 (45%), which is a C-glycosyltransferase HHGGAGT and the strictly conserved Pro and Asp (the
potential catalytic base for proton abstraction of an ac-responsible for angolosamine transfer in medermycin
(17) biosynthesis (S. sp. AM7161) [39]. HedL shows sig- ceptor hydroxyl) residues within these transferases. In-
terestingly, the Gly-rich motif and the Pro residue arenificant homology to the single glycosyltransferase
found in the granaticin biosynthetic cluster, which is also found in HedJ and HedL, while the Asp residue is
replaced by the amino acids Lys and Ala, respectively, inpostulated to be involved in the attachment of a 4-keto-
2,6-dideoxy-D-glucose to the granaticin aglycon via two these putative C-glycosyltransferases. Consistent with
this observation, Ichinose et al. have postulated thatC-C bonds (S. violaceoruber) [40]. Amino acid alignment
of the HedJ and HedL to UrdGT2 also shows that the this putative general base (Asp) is mainly restricted to
O-glycosyltransferases [39]. Similar comparison of theproteins share significant identity (HedJ, 40% and HedL,
58%, respectively, S. fradiae Tu¨ 2717). UrdGT2, a C-gly- two C-glycosyltransferases from the 14 cluster with all
other C-glycosyltransferases so far identified and othercosyltransferase from the urdamycin (16) biosynthetic
gene cluster, has thus far been established as the en- close O-GT homologs illustrate that the most common
replacement is with nonpolar residues such as Ala, Val,zyme responsible for attaching the first D-olivose to the
aglycon via a C-C linkage [41]. and Ile. In contrast, the C-glycosyltransferases HedJ
and Gra-Orf-14 both contain a basic Lys substitution.Most, if not all, UDP/TDP glycosyltransferases, which
comprise by far the largest category of glycosyltransfer- At least two mechanisms can be put forth for the
C-glycosylation of the aromatic aglycon of 14. The firstases, fall into two different structural superfamilies [42].
These superfamilies have different folds, different active mechanism (mechanism I) requires O-glycosylation of
the phenolic hydroxyl followed by an O-C rearrangementsites, and different mechanisms. The GT-A superfamily
employs a DXD motif to bind a divalent metal ion (most and has been proposed for the C-glycosylation of ortho-
C-substituted C-glycosides (Figure 6A). Chemical mod-commonly Mn2). The metal ion, which is essential for
catalysis, helps anchor the pyrophosphoryl group of the els promoted by Lewis acids exist, which demonstrate
the facile rearrangement of O-aryl glycosides to theUDP-sugar donor in the enzyme active site. The GT-B
family carries a two-domain structure, and each domain ortho-C-analogs and some minor para-C-substituted
variants, with typically the -glycoside as the predomi-adopts an / open-sheet motif similar to a classic Ross-
mann fold, which is thought to be involved in binding nate product [17, 18, 44]. The second mechanism (mech-
anism II, Figure 6B) is analogous, in a regiochemicalthe glycosyl donors.
A more recent structural study of the UDP-glucosyl- sense, to a direct Friedel-Crafts aromatic substitution
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reaction. Support for this mechanism derives predomi- Three genes were identified to have no obvious role
in the biosynthesis of 14. OrfH3 encodes a protein withnantly from chemical models in which a distinctive Lewis
acid, Cp2ZrCl2-AgClO4, promoted the efficient coupling great homology to tripeptidyl aminopeptidase (TAP)
from S. lividans. The S. lividans gene has been cloned,of methoxynapthalene derivatives with glycosyl fluo-
rides to give both the ortho- and para-C-glycosides, the and cross-species hybridization experiments showed
that homologs are present in most of the Streptomyces-glycoside predominating [45, 46]. The regiochemistry
of aromatic substitution patterns in these studies corre- strains tested [53]. OrfH4 and orfH10 encode a highly
conserved hypothetical protein and a hydrolase, respec-lated well with the predicted reactivity of each methoxy-
naphthalene starting unit. While the products of mecha- tively, found in most secondary metabolite producing
Streptomyces.nism II are most consistent with the formation of 14,
C-glycosyltransferase mechanistic studies are com-
pletely lacking and future efforts will be focused on Significance
in vivo and in vitro characterization of these proteins to
determine this novel enzymatic mechanism. Hedamycin is an aromatic polyketide distinguished for
its di-C-glycoside architecture. It is a potent DNA alkyl-
ating agent and in-depth structural studies have
NDP-Sugar Biosynthesis, Regulation, Resistance, shown that the sugar moieties play a crucial role for
and Unknown Function its specific interaction with DNA. The biosynthetic en-
Blast analysis indicates that the putative genes involved zymes responsible for the sugar modification of this
in the biosynthesis of the two deoxyamino sugars bear natural product provide a platform for elucidating the
great protein similarity to the enzymes involved in the unknown mechanisms of enzymatic C-glycosylation
biosynthesis of dTDP-L-vancosamine. This well-studied and, moreover, offer an attractive tool for bioengineer-
pathway sets the foundation for the proposed biosyn- ing novel C-glycosides. Toward this effort, the cloning
thetic scheme presented in Figure 5 [47]. The early bio- and initial characterization of the core of the biosyn-
synthetic steps of 2,6-deoxygenation and amino transfer thetic genes encoding for hedamycin biosynthesis re-
are expected to follow precedent, providing the com- vealed the candidate C-glycosyltransferase genes and
mon precursor 28 from which the pathways diverge to additional unique enzymes that implicate a novel aro-
32 and 34, respectively, via reduction or methylation/ matic PKS priming mechanism. The proposed biosyn-
epimerization/reduction as illustrated. The equivalent thetic pathway involves the collaborative action of the
genes encoding Ep and the methyltrasferase, not present starter unit-specific HedS (KSIII) and HedF (AT) in con-
in the current 14 locus, were identified in the 12 locus junction with an adjacent iterative type I PKS system,
and are presumed to also be necessary for 14 biosynthe- HedT and HedU, for the generation and utilization of
sis (T.B., C.-G.H., and J.S.T., unpublished data). a de novo hexenoate primer for subsequent aromatic
Database searches revealed three genes with proba- polyketide biosynthesis. This remarkable assembly of
ble regulatory function in the cluster. The orfH5 encoded a type I and type II PKS system for the biosynthesis
protein shows similarity to transcriptional activators of of a natural product is an original finding and as the
the Streptomyces antibiotic regulatory protein (SARP) first elucidation of a locus encoding for the biosynthe-
family. They are proposed to activate transcription of sis of a pluramycin class of antitumor antibiotics, this
target structural genes by binding to direct heptameric work should greatly impact upon understanding the
repeats sometimes found overlapping the –35 regions biosynthesis of other members within this important
of cognate promoters [48]. The protein product of orfH2 class of natural product.
exhibits slight homology to tetR-family of regulatory pro-
teins. OrfH9 is a close homolog of DnrO, which is pro- Experimental Procedures
posed to be a transcriptional repressor protein (S. peu-
Bacterial Strains, Culture Conditions, and Vectorscetius) [49].
Streptomyces griseoruber ATCC 15422 cells were grown at 28CSelf-resistance is an important requirement for antibi-
and 225 rpm in baffled flasks containing beads (2.5 g). Escherichiaotic producing microorganisms, and the 14 cluster con-
coli DH5, VCS257 (Stratagene), and GM2163 (New England Biolab)
tains several genes that are self-resistance candidates. were cultured in LB at 37C with the appropriate antibiotic selection
OrfH1 encodes a protein with significant homology to at a final concentration of 100 g mL1 ampicillin, 50 g mL1 apra-
mycin, 25 g mL1 chloramphenicol, and streptomycin. Bacillusthe mct gene, which encodes a protein involved in a
subtilis ATCC 6633 was grown at 30C in nutrient media accordingnovel drug export system, from the mitomycin biosyn-
to the ATCC recommendations. Vectors pGEM-T easy vectors (Pro-thetic gene cluster (S. lavendulae) [50]. OrfH6 and orfH7
mega), pBS II SK (Stratagene) and pKC1138 were previously de-genes resemble those encoding ABC transporter sys-
scribed. The shuttle vector pDW103, a pOJ446 derivative in which
tems from antibiotic-producing actinomycetes. These the apramycin resistance cassette is replaced by thiostrepton and
proteins show highest homology to the resistance fac- ampicillin cassette, was used for cosmid library construction [54].
tors, AviABC1-AviABC2 proteins, from the avilamycin
biosynthetic gene cluster (S. viridochromogenes) [51]. Genetic Procedures
Total DNA isolation, plasmid DNA preparations, restriction endonu-OrfH11 encodes a 760 amino-acid protein with strong
clease digestions, ligations, and transformation were performed ac-sequence similarity to the E. coli and Micrococcus luteus
cording to standard procedures for E. coli. Total cellular DNA isola-UvrA proteins involved in excision repair of DNA. It also
tion and methods for preparation of S. griseoruber spores and
shares 66% homology to DrrC, an UvrA-like protein, protoplasts were those described previously [55]. For cosmid library
which has been confirmed to be important for daunoru- construction, genomic DNA from S. griseoruber was partially di-
gested with Sau3A and calf intestine alkaline phosphatase treatedbicin resistance in vitro (S. peucetius)[52].
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according to the manufacturing instructions. The fragments were detection were performed according to literature procedures and
manufacturer recommendations (Roche).ligated to BamHI-digested pDW103 and packaged into lambda
phage particles by using Stratagene Gigapack III XL as per instruc-
tion and plated on E. coli VCS257. Single random bacterial clones Isolation and Detection of Hedamycin
were combined together in groups of fifty and the complete plasmid from S. griseoruber and Mutants
DNA isolated from the pools was screened by diagnostic PCR using The strains were grown in production media consisting of 2.0%
three sets of degenerate primers that amplify deoxysugar biosyn- cerelose, 1.0% pharmamedia, 1.0% corn steep liquor, 0.40% cal-
thetic genes such as the dTDP-glucose-4,6-dehydratase (5- cium carbonate, 0.30% ammonium sulfate, and 0.003% zinc sulfate
GTSACSGGSGGSGCSGGSTTCAT-SGG-3 and 5-CTGGTASGGS [7]. The fermentations were carried out in New Brunswick rotary
CCGTAGTTGTT-3) and glycosyltransferase (5-GCSTGGGCSCT shakers (260 rpm) in 500 ml baffled flasks containing 100 ml of the
SMR-SDSSGCSGGSCACGA-3 and 5-GTSCCSSHSCCSCCGTGG above medium for 4 days at 28C. The organic layer from a whole-
TGSA-3), and the aromatic PKS gene KS (5-GSMGSGTSGTSAT cell CHCl3 extract was concentrated and analyzed on HPLC (C18
SACSGGSATSGG-3 and 5-CTGGAASCC- SCCGAASCCSSWSCC reverse phase chromatography, 250 4.6 mm, flow rate 1 ml min1,
SAC-3). Amplified PCR products were sublconed into pGEM-T easy 	
 245 nm, 5% CH3CN 95% 0.1% aqueous H3PO4 to 58% CH3CN
vectors and sequenced. 42% 0.1% aqueous H3PO4, 45 min). The hedamycin production rate
in these shake-flask fermentation conditions was comparable to a
previously reported result of 60 mg L1 from large scale fermentorsDNA Sequencing and Analysis
[7]. A 14 standard under the above HPLC conditions had a retentionCosmid clones were shotgun sequenced by the Genome Center,
time of 32 min.University of Wisconsin, Madison, WI. Specifically, intact cosmids
were mechanically sheered and fragments in the size range of 1–3
Biological Tests for Hedamycin Antibacterial Activitykb were purified by preparative agarose gel electrophoresis and
Growth inhibition tests on B. subtilis were used to visualize in vivosubcloned into SmaI-digested plasmid Bluescript II SK (Stra-
antibacterial activity [7]. Specifically, aliquots of the CHCl3 whole-tagene). Plasmid subclones were isolated by using Qiagen columns.
cell extracts were added to paper discs and placed on a lawn ofAutomated sequencing was done on double stranded DNA tem-
B. subtilis overlaid onto nutrient agar plates. The plates were incu-plates. Sequence data obtained from single random subclones (700
bated at 30C overnight. Standard 14/CHCl3 solutions were used asfor each cosmid) was assembled and edited by using the SeqMan
positive controls while CHCl3 and CHCl3 whole-cell extract fromsoftware (DNAStar). ORF searches were done by using the frameplot
nonproducing strains (e.g., S. lividans K4-114) served as negativesoftware available at the website http://www.nih.go.jp/jun/cgi-bin/
controls.frameplot-3.0b.pl. Database comparison was performed with the
BLAST search tools on the server of the National Center for Biotech-
nology Information, Bethesda, MD. The DNA sequence has been Acknowledgments
deposited in the GenBank under the accession number AY196994.
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Note Added in Proof
Evidence to support mechanism II (Figure 6B) for UrdGT2 has re-
cently been reported. Durr, C., Hoffmeister, D., Wohlert, S.-E., Ichi-
nose, K., Weber, M., von Mulert, U., Thorson, J.S., and Bechthold,
A. (2004). The glycosyltransferase UrdGT2 catalyzes both C- and
O-glycosidic sugar transfers. Angew. Chem. Int. Ed. 43, 2962–2965.
